EMA starts review of ipidacrine-containing medicines

View source ↗

Summary

EMA has started a review of medicines containing ipidacrine to evaluate their effectiveness for authorised uses and to assess potential liver safety risks.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Dementia

Drugs mentioned

• Ipidacrine (ipidacrine)

Snippet

Review will evaluate effectiveness in authorised uses and liver safety